RYR3: Ryanodine receptor 3
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm in muscle and thereby plays a role in triggering muscle contraction.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it.| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Dantrolene | Approved | Ryanodine receptor 3 antagonist | Antagonist | Boxed warning |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Congenital myopathy 20
- 0.61
- Fever
- 0.52
- Stroke disorder
- 0.43
- Neurodegenerative disease
- 0.37
- Nemaline myopathy
- 0.37
- Cerebral palsy
- 0.37
- Malignant hyperthermia of anesthesia
- 0.37
- Spasticity
- 0.37
- Hydrops fetalis
- 0.34
- Primary ovarian failure
- 0.31
- Lobular capilliary hemangioma
- 0.29
Drugs and mechanisms are from ChEMBL CHEMBL2062 (CC BY-SA 3.0). Gene name, function (UniProt Q15413, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets